Roquinimex
|
|
- CAS-Nr.
- 84088-42-6
- Englisch Name:
- Roquinimex
- Synonyma:
- FCF89;LS-2616;CS-1231;LINOMIDE;ABR212616;ROQUINIMEX;PNU 212616;Roquinimex(Linomide);N,1-Dimethyl-N-phenyl-2-oxo-4-hydroxy-1,2-dihydroquinoline-3-carboxamide;1,2-Dihydro-4-hydroxy-1,N-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide
- CBNumber:
- CB2391777
- Summenformel:
- C18H16N2O3
- Molgewicht:
- 308.33
- MOL-Datei:
- 84088-42-6.mol
|
Roquinimex Eigenschaften
- Schmelzpunkt:
- 200-204°
- Siedepunkt:
- 436.2±45.0 °C(Predicted)
- Dichte
- 1.357±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,2-8°C
- L?slichkeit
- DMSO: 11 mg/mL
- pka
- 4.50±1.00(Predicted)
- Aggregatzustand
- solid
- Farbe
- White to off-white
- Merck
- 14,8259
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Kennzeichnung gef?hrlicher |
Xn |
|
|
R-S?tze: |
22 |
|
|
S-S?tze: |
36/37 |
|
|
RIDADR |
UN 2811 6.1/PG 3 |
|
|
WGK Germany |
3 |
|
|
HS Code |
2933.49.2600 |
|
|
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
Sicherheit |
P264 |
Nach Gebrauch gründlich waschen. |
P264 |
Nach Gebrauch gründlich waschen. |
P270 |
Bei Gebrauch nicht essen, trinken oder rauchen. |
P330 |
Mund ausspülen. |
|
Roquinimex Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R22:Gesundheitssch?dlich beim Verschlucken.
S-S?tze Betriebsanweisung:
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
Beschreibung
Roquinimex is an immunomodulator with diverse biological activities.
In vivo, roquinimex (80 mg/kg) increases the number of myocardial MHC class II-expressing cells, the ratio of cytotoxic to helper T cells, and survival and decreases necrotic lesion area in a mouse model of murine coxsackievirus B3-induced myocarditis. It induces IFN-γ production, reduces TNF-α and IL-1β production, prevents the development of proteinuria, and ameliorates nephritis in a mouse model of chronic graft versus host disease (GVHD). Roquinimex (300 mg/kg) decreases colonic myeloperoxidase (MPO) activity and mucosal damage in a mouse model of colitis induced by dextran sulfate (DSS; ). It also decreases tumor weight and tumor blood flow in a von Hippel-Lindau (VHL) type 2a paraganglioma mouse xenograft model.
Verwenden
Biological response modifier; immunomodulator.
Biologische Aktivit?t
Immunomodulator with stimulatory and antitumor properties. Inhibits in vivo apoptosis of T-cells and inhibits angiogenesis in rats in vivo .
Roquinimex Upstream-Materialien And Downstream Produkte
Upstream-Materialien
3-Quinolinecarboxylic acid, 1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-
methyl 3-(N-methyl-N-phenylamino)-3-oxopropanoate
3-Quinolinecarboxylic acid, 1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-, Methyl ester
1,2-DIHYDRO-4-HYDROXY-1-METHYL-2-OXO-3-QUINOLINECARBOXYLIC ACID ETHYL ESTER
1-Methyl-2H-3,1-benzoxazin-2,4(1H)-dion
4H-3,1-Benzoxazin-2,4(1H)-dion
N-Methyl-anilin
Anthranilic acid
Downstream Produkte
Roquinimex Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 112)Lieferanten
84088-42-6()Verwandte Suche:
- N-PHENYLMETHYL-1,2-DIHYDRO-4-HYDROXYL-N,1-DIMETHYL-2-OXO-QUINOLINE-3-CARBOXAMIDE
- ROQUINIMEX
- LINOMIDE
- LS-2616
- 1,2-DIHYDRO-4-HYDROXY-N,1-DIMETHYL-2-OXO-N-PHENYL-3-QUINOLINECARBOXAMIDE
- 1,2-DIHYDRO-4-HYDROXY-N,N-DIMETHYL-2-OXO-N-PHENYL-3-QUINOLINECARBOXAMIDE
- 4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
- 1,2-Dihydro-4-hydroxy-1,N-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide
- N,1-Dimethyl-N-phenyl-2-oxo-4-hydroxy-1,2-dihydroquinoline-3-carboxamide
- PNU 212616
- N-phenyl-N-Methyl-1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-quinoline-3-carboxaMide
- CS-1231
- Roquinimex(Linomide)
- ABR212616
- FCF89
- 3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-
- Tumor Necrosis Factor Receptor,FCF-89,TNF Receptor,TNFR,Roquinimex,Inhibitor,ABR-212616,ABR 212616,FCF 89,inhibit
- 84088-42-6
- C18H16N2O3
- Cell Signaling and Neuroscience
- Cell Biology
- BioChemical
- Immune System Regulation
- Immunomodulators and Antibiotics
- Immune Cell Signaling and Blood
- Antitumour